StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
VANDAN.BO$31.63-4.44%
Fair $31.63+0.0%

VANDAN.BO

Vandan Foods Limited

Consumer Defensive / Farm ProductsBSE

$31.63

-1.47 (-4.44%)

Fairly Valued+0.0%Fair Value $31.63Fund rank 23/100 · Data gapFallback financials|
SA 32/D
F-Score: 1/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-183.2M · quality 39.7/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 4/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

32/100

D

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: unknownPeriods: 5Warnings: 1unknown: 5
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 2.8%, below the 5% threshold
Thesis & Journal · VANDAN.BOLocal privado en este navegador · Vandan Foods Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$265M

P/E

18.4x

↑

EV/EBITDA

10.0x

↑

ROE

2.8%

↓

Gross Margin

5.2%

↓

Debt/Equity

0.52

↑
52-Week Range$32
$30$107

TradingView lightweight chart

VANDAN.BO price, volumen y niveles de valoración

Último $31.63Periodo -70.5%
Fair value: $31.63

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2026 · 4 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

—

FCF margin

-13.6%

FCF / Net income

-26.66x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.60B · net income $13.2M · FCF $-352.9M

2022-FY → 2026-FY

Gross margin

5.2%— pts

Operating margin

1.4%— pts

Net margin

0.5%— pts

FCF margin

-13.6%— pts
MetricTTM
2026
2025
2024
2023
2022
Income Statement
Revenue$2.60B$2.60B$1.08B$487.3M$115.9M—
Net Income$13.2M$13.2M$69.1M$26.4M$6.4M—
EBITDA$51.4M$51.4M$104.8M$36.5M$9.9M—
EPS——8.243.150.77-0.14
Gross Margin5.2%5.2%13.7%11.3%30.4%—
Operating Margin1.4%1.4%9.5%7.3%7.4%—
Net Margin0.5%0.5%6.4%5.4%5.5%—
Balance Sheet
Debt/Equity0.520.52——0.18-73.62
Current Ratio1.381.38————
Cash Flow
Free Cash Flow$-352.9M$-352.9M$-183.2M$-44.8M$26.1M—
Returns
ROE2.8%2.8%—27.9%29.5%—
Valuation
P/E18.3918.39————
EV/EBITDA10.0110.01————
P/B0.550.55————
Growth & Yield
Revenue Growth140.0%140.0%122.0%320.3%——
EPS Growth——161.2%311.4%662.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · available periodreconcilia total -70.5%

Total return

-70.5%

Start / end P/E

n/dx → n/dx

EPS bridge

8.24 → n/d

Residual

-70.5%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-70.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.